No results for ‘’
Shukra Pharmaceuticals Ltd
₹58.59
(5.89%)
Fri, 25 Sept 2026, 08:47 am
Shukra Pharmaceuticals Share Price Live Chart
1 Day
(5.89%)
No Result Found
Summary
Market Cap (in Cr)
1269.41
Net Profit (in Cr)
9.58
P/B
15.17
Sector P/E
33.76
P/E
99.32
EV/EBITDA
56.04
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.81
ROCE (Industry)
16.40
RONW (Industry)
14.39
ROE
15.90
ROCE
21.76
Debt/Equity
0.06
EPS (TTM)
0.50
Dividend Yield
0
Book Value
2.05
Interest Cover
23.61
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 50.96 | 50.96 | 50.96 | 50.96 | 50.96 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 |
| Public | 48.93 | 48.93 | 48.93 | 48.93 | 48.93 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 72.72 | 56.45 | 50.43 | 40.18 | 34.16 | 23.91 | 7.64 |
| Fibonacci | 56.45 | 50.23 | 46.40 | 40.18 | 33.96 | 30.13 | 23.91 |
| Camarilla | 48.88 | 47.39 | 45.90 | 40.18 | 42.92 | 41.43 | 39.94 |
Pivots Level: Classic
R3
+32.54
72.72
R2
+16.27
56.45
R1
+10.25
50.43
S1
-6.02
34.16
S2
-16.27
23.91
S3
-32.54
7.64
Moving Average
Period
Value
10-EMA
55.36
20-EMA
52.73
30-EMA
50.08
50-EMA
46.05
100-EMA
41.38
200-EMA
37.93
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 07 May 2026 | board-meetings | Accounts, Final Dividend | |
| 04 Feb 2026 | board-meetings | Quarterly Results | |
| 13 Nov 2025 | board-meetings | Quarterly Results | |
| 04 Oct 2025 | egm | ||
| 30 Aug 2025 | agm | ||
| 18 Aug 2025 | dividend | Final Dividend - Rs. - 0.01 | 18 Sept 2025 |
| 04 Jun 2025 | dividend | ₹0.01 Dividend /Share | 18 Sept 2025 |
| 21 Feb 2025 | split | Stock Split From Rs.10 to Rs.1 | 21 Mar 2025 |
| 29 Jan 2025 | split | 1:10 Splits of Equity Shares | 21 Mar 2025 |
| 15 Sept 2024 | agm |
Peer Comparison
Shukra Pharmaceuticals Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Divis Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Shukra Pharmaceuticals Ltd About
Shukra Pharmaceuticals is engaged primarily in the business of manufacture and marketing of pharmaceutical products.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1993
Headquarters
CEO
Dakshesh Shah
Employees
Contact
Website
http://www.shukrapharmaceuticals.com
info@shukrapharmaceuticals.com
Phone
91-079-66522247/27498515
Location
3 rd Floor Dev House, Opp WIAA Office Judges Bungalo, Ahmedabad, Gujarat, 380054
Frequently Asked Questions
1.What is the stock price of Shukra Pharmaceuticals Ltd?
As of 25/09/2026 at 2:17 PM, Shukra Pharmaceuticals Ltd shares are trading at ₹58.59.
2.What is the market cap. of Shukra Pharmaceuticals Ltd?
As of 25/09/2026, the market capitalization of Shukra Pharmaceuticals Ltd is ₹2,428.43 crore.
3.When was Shukra Pharmaceuticals Ltd founded?
Shukra Pharmaceuticals Ltd was founded in 1993.
4.What are the P/E and P/B ratios of Shukra Pharmaceuticals Ltd?
As of 25/09/2026, Shukra Pharmaceuticals Ltd has a P/E ratio of 75.60 and a P/B ratio of 15.17.
5.How can I buy shares of Shukra Pharmaceuticals Ltd?
You can buy shares of Shukra Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.Does Shukra Pharmaceuticals Ltd pay dividends?
Yes, Shukra Pharmaceuticals Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 0.01 per share.
7.What is the dividend yield of Shukra Pharmaceuticals Ltd?
As of 25 September, 2026, the dividend yield of Shukra Pharmaceuticals Ltd stands at 0.02%.
8.What are the latest financial results of Shukra Pharmaceuticals Ltd?
For January,2024, Shukra Pharmaceuticals Ltd reported revenue of ₹32.59 crore and a net profit of ₹9.58 crore.
9.Who is the CEO of Shukra Pharmaceuticals Ltd?
The CEO of Shukra Pharmaceuticals Ltd is Dakshesh Shah.